申请人:Pfizer Inc.
公开号:US20170137801A1
公开(公告)日:2017-05-18
The present application provides compounds, compositions, uses thereof for the treatment of diseases, conditions and/or disorders, and uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.